Medifocus Inc. Announces Extension of Convertible Debenture Financing
17 January 2014 - 8:19AM
Marketwired
Medifocus Inc. Announces Extension of Convertible Debenture
Financing
COLUMBIA, MARYLAND and TORONTO, ONTARIO--(Marketwired - Jan 16,
2014) - Medifocus Inc. (TSX-VENTURE:MFS)(OTCQX:MDFZF) announced
today the extension of the final closing of its non-brokered
private placement (the Offering) of $6,000,000 previously announced
in August 2013. The Company previously disclosed the completion of
the first tranche of the Offering, in an amount of $3,540,000, on
December 18, 2013 and now expects to complete the Offering by
February 14, 2014. All other terms and conditions of the Offering
remain unchanged.
About Medifocus
Medifocus owns two fully developed technology platforms with
comprehensive United States and international patent protection:
(i) The Endo-thermotherapy Platform-a catheter-basis focused heat
technology platform that utilizes natural body openings to deliver
precise microwave thermotherapy to the diseased sites. The United
States Food and Drug Administration (FDA) approved Prolieve
Thermodilatation System for the treatment of Benign Prostatic
Hyperplasia (BPH) was developed based on the Endo-thermotherapy and
is currently generating revenue; and (ii) the Adaptive Phased Array
(APA) Microwave Focusing Platform, invented by the Massachusetts
Institute of Technology, licensed to Medifocus directs precisely
focused microwave energy at tumor center to induce shrinkage or
eradication of tumors without undue harm to surrounding tissue.
Medifocus' APA 1000 Breast Cancer Treatment System, developed from
the APA technology platform, has received approval from the FDA and
Health Canada to conduct the pivotal Phase III clinical trials.
Medifocus believes that these two technology platforms can provide
the design basis for the development of multiple cancer treatment
systems for surface, subsurface and deep seated localized and
regional cancers. Please visit www.medifocusinc.com,
www.prolieve.com and
www.facebook.com/pages/Medifocus-Inc-Company-Page/546315028715627
for more details.
Forward-Looking Statements and Information
This news release contains "forward-looking statements" and
"forward-looking information", which may not be based on historical
facts. Forward-looking statements and forward-looking information,
include, but are not limited to, information and statements with
respect the structure and the proceeds of the Offering and the
expected use of the proceeds. Forward-looking statements are
frequently characterized by words such as "plan," "expect,"
"project," "intend," "believe," "anticipate", "estimate" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made. Such forward-looking statements and forward-looking
information involve known and unknown risks, uncertainties and
other factors that may cause the actual results events or
developments to be materially different from any future results,
events or developments expressed or implied by such forward-looking
statements or forward-looking information. These factors should be
considered carefully and readers are cautioned not to place undue
reliance on such forward-looking statements and forward-looking
information. Except as required by applicable securities laws,
Medifocus disclaims any obligation to update any such factors or to
publicly announce the results of any revisions to any of the
forward-looking statements or forward-looking information contained
herein to reflect future results, events or developments.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Medifocus Inc.John
MonCOO410-290-5734JohnMon@medifocusinc.comwww.medifocusinc.comInvestor
Relations Contact:Consulting for Strategic Growth 1Robert
Giordano917-327-3938rgiordanonyc@gmail.com
Medifocus (CE) (USOTC:MDFZF)
Historical Stock Chart
From May 2024 to Jun 2024
Medifocus (CE) (USOTC:MDFZF)
Historical Stock Chart
From Jun 2023 to Jun 2024